Please use this identifier to cite or link to this item:
https://doi.org/10.3390/ijms24010713
DC Field | Value | |
---|---|---|
dc.title | The Management of Ocular Surface Squamous Neoplasia (OSSN) | |
dc.contributor.author | Yeoh, Clarice HY | |
dc.contributor.author | Lee, Jerome JR | |
dc.contributor.author | Lim, Blanche XH | |
dc.contributor.author | Sundar, Gangadhara | |
dc.contributor.author | Mehta, Jodhbir S | |
dc.contributor.author | Chan, Anita SY | |
dc.contributor.author | Lim, Dawn KA | |
dc.contributor.author | Watson, Stephanie L | |
dc.contributor.author | Honavar, Santosh G | |
dc.contributor.author | Manotosh, Ray | |
dc.contributor.author | Lim, Chris HL | |
dc.date.accessioned | 2023-11-06T07:43:23Z | |
dc.date.available | 2023-11-06T07:43:23Z | |
dc.date.issued | 2023-01 | |
dc.identifier.citation | Yeoh, Clarice HY, Lee, Jerome JR, Lim, Blanche XH, Sundar, Gangadhara, Mehta, Jodhbir S, Chan, Anita SY, Lim, Dawn KA, Watson, Stephanie L, Honavar, Santosh G, Manotosh, Ray, Lim, Chris HL (2023-01). The Management of Ocular Surface Squamous Neoplasia (OSSN). INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24 (1). ScholarBank@NUS Repository. https://doi.org/10.3390/ijms24010713 | |
dc.identifier.issn | 1661-6596 | |
dc.identifier.issn | 1422-0067 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/245760 | |
dc.description.abstract | The rise of primary topical monotherapy with chemotherapeutic drugs and immunomodulatory agents represents an increasing recognition of the medical management of ocular surface squamous neoplasia (OSSN), which may replace surgery as the standard of care in the future. Currently, there is no consensus regarding the best way to manage OSSN with no existing guidelines to date. This paper seeks to evaluate evidence surrounding available treatment modalities and proposes an approach to management. The approach will guide ophthalmologists in selecting the most appropriate treatment regime based on patient and disease factors to minimize treatment related morbidity and improve OSSN control. Further work can be done to validate this algorithm and to develop formal guidelines to direct the management of OSSN. | |
dc.language.iso | en | |
dc.publisher | MDPI | |
dc.source | Elements | |
dc.subject | Science & Technology | |
dc.subject | Life Sciences & Biomedicine | |
dc.subject | Physical Sciences | |
dc.subject | Biochemistry & Molecular Biology | |
dc.subject | Chemistry, Multidisciplinary | |
dc.subject | Chemistry | |
dc.subject | ocular surface squamous neoplasia | |
dc.subject | management | |
dc.subject | topical chemotherapy | |
dc.subject | 5-fluorouracil (5-FU) | |
dc.subject | mitomycin C (MMC) | |
dc.subject | interferon alfa (INF alpha) | |
dc.subject | surgical excision | |
dc.subject | adjuncts | |
dc.subject | TOPICAL MITOMYCIN-C | |
dc.subject | CORNEAL INTRAEPITHELIAL NEOPLASIA | |
dc.subject | AMNIOTIC MEMBRANE TRANSPLANTATION | |
dc.subject | LIMBAL EPITHELIAL TRANSPLANTATION | |
dc.subject | OPTICAL COHERENCE TOMOGRAPHY | |
dc.subject | VIVO CONFOCAL MICROSCOPY | |
dc.subject | HUMAN PAPILLOMA-VIRUS | |
dc.subject | CELL CARCINOMA | |
dc.subject | SUBCONJUNCTIVAL RANIBIZUMAB | |
dc.subject | INTRAOCULAR INVASION | |
dc.type | Review | |
dc.date.updated | 2023-11-06T05:27:06Z | |
dc.contributor.department | OPHTHALMOLOGY | |
dc.contributor.department | DUKE-NUS MEDICAL SCHOOL | |
dc.description.doi | 10.3390/ijms24010713 | |
dc.description.sourcetitle | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | |
dc.description.volume | 24 | |
dc.description.issue | 1 | |
dc.published.state | Published | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
The Management of Ocular Surface Squamous Neoplasia (OSSN).pdf | 1.22 MB | Adobe PDF | OPEN | Published | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.